Watch GEHC. Know when insiders buy.
One email the day a filing lands. Free.
GEHC
GE HealthCare Technologies Inc.
69.01
−1.22 −1.74%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
30
FLAG · shorts 30
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $31.4BP/E 16.5DIV YIELD 0.20%FCF YIELD 4.84%REV TTM $21B +6.0%NET INCOME $1.9B −12.5%NET DEBT $7.9B52W 59.49 – 88.16SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $5.1B | +7.4% | 38.5% | $515M | $389M | −31.0% | 0.85 | $290M | $178M | $112M | Apr 29 |
| Q4 2025 · Dec 31derived | $5.7B | +7.1% | 39.7% | $827M | $589M | −18.3% | 1.29 | $1.1B | $134M | $916M | Feb 4 |
| Q3 2025 · Sep 30 | $5.1B | +5.8% | 38.7% | $653M | $446M | −5.1% | 0.98 | $593M | $110M | $483M | Oct 29 |
| Q2 2025 · Jun 30 | $5B | +3.5% | 39.6% | $654M | $486M | +13.6% | 1.06 | $94M | $86M | $8M | Jul 30 |
| Q1 2025 · Mar 31 | $4.8B | +2.7% | 42.1% | $629M | $564M | +50.8% | 1.23 | $250M | $152M | $98M | Apr 29 |
| Q4 2024 · Dec 31derived | $5.3B | +2.2% | 42.8% | $801M | $721M | +78.9% | 1.57 | $913M | $102M | $811M | Feb 4 |
| Q3 2024 · Sep 30 | $4.9B | +0.9% | 41.7% | $676M | $470M | +25.3% | 1.02 | $742M | $90M | $652M | Oct 29 |
| Q2 2024 · Jun 30 | $4.8B | +0.5% | 41.4% | $608M | $428M | +2.4% | 0.93 | −$119M | $64M | −$183M | Jul 30 |
| Q1 2024 · Mar 31 | $4.7B | — | 40.9% | $540M | $374M | — | 0.81 | $419M | $145M | $274M | Apr 30 |
| Q4 2023 · Dec 31derived | $5.2B | — | 41.4% | $689M | $403M | — | 0.88 | $1.1B | $94M | $956M | Feb 4 |
| Q3 2023 · Sep 30 | $4.8B | — | 40.1% | $617M | $375M | — | 0.82 | $650M | $80M | $570M | Oct 30 |
| Q2 2023 · Jun 30 | $4.8B | — | 40.3% | $570M | $418M | — | 0.91 | −$67M | $70M | −$137M | Jul 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $20.6B | 40.0% | $2.8B | $2.1B | 10.1% | 4.55 | $2B | $482M | $1.5B | $200M | $64M |
| FY2024 · to Dec 31 | $19.7B | 41.7% | $2.6B | $2B | 10.1% | 4.34 | $2B | $401M | $1.6B | $0 | $55M |
| FY2023 · to Dec 31 | $19.6B | 40.5% | $2.4B | $1.6B | 8.0% | 3.03 | $2.1B | $387M | $1.7B | $0 | $41M |
| FY2022 · to Dec 31 | $18.3B | 39.1% | $2.5B | $1.9B | 10.4% | 4.22 | $2.1B | $310M | $1.8B | — | $0 |
| FY2021 · to Dec 31 | $17.6B | 40.8% | $2.8B | $2.2B | 12.8% | 4.95 | $1.6B | $248M | $1.4B | — | $0 |
Every number comes from GE HealthCare Technologies Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.